Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...